In our study, patients with diabesity and liver fibrosis were characterized by lower mean corpuscular volume (MCV), lower platelet count, higher RDW-CV, higher aminotransferase activity, lower albumin levels, and a higher percentage of HbA1c. This evidence concerns the gene ALB and Hepatic fibrosis.